TA
CRNX icon

Teachers Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Teachers Advisors’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$269K Hold
11,836
– – ﹤0.01% 2759
2018
Q4 		$355K Buy
11,836
+2,756
+30% +$77.6K ﹤0.01% 2655
2018
Q3 		$260K Buy
+9,080
New +$270K ﹤0.01% 2864

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Teachers Advisors's CRNX Position: Q1 2019 in Review

Teachers Advisors held its Crinetics Pharmaceuticals (CRNX) position steady in Q1 2019 at 11,836 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #2759.

Teachers Advisors first reported a position in CRNX in Q3 2018 and has held it in 3 quarters since. The position peaked at $355K in Q4 2018. 62 funds tracked by Wall St. Rank hold CRNX as of Q1 2019.

  • Teachers Advisors held 11,836 shares of Crinetics Pharmaceuticals worth $269K as of Q1 2019.
  • Teachers Advisors left its Crinetics Pharmaceuticals share count unchanged in Q1 2019.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2759 holding.
  • Teachers Advisors first reported a position in Crinetics Pharmaceuticals in Q3 2018 and has held it in 3 quarters since.
  • Teachers Advisors's Crinetics Pharmaceuticals position peaked at $355K in Q4 2018.
  • 62 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.